S Kroep1, I Lansdorp-Vogelaar1, J H Rubenstein2, V E P P Lemmens3, E B van Heijningen1, N Aragonés4, M van Ballegooijen1, J M Inadomi5. 1. Department of Public Health, Erasmus Medical Center University, Rotterdam, The Netherlands. 2. Division of Gastroenterology, Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA. 3. 1] Department of Public Health, Erasmus Medical Center University, Rotterdam, The Netherlands [2] Eindhoven Cancer Registry, Department of Research, Eindhoven, The Netherlands. 4. 1] Cancer and Environmental Epidemiology Area, National Centre for Epidemiology, Carlos III Institute of Health, Madrid, Spain [2] CIBER in Epidemiology and Public Health, Barcelona, Spain. 5. Division of Gastroenterology, Department of Medicine, University of Washington, Seattle, Washington, USA.
Abstract
OBJECTIVES: The incidence of esophageal adenocarcinoma (EAC) in the western world has been rapidly increasing. The trends in obesity and other lifestyle-associated factors have been hypothesized to be important drivers of this increase. We tested this hypothesis by comparing changes in these factors with changes in EAC incidence over time between three western countries. METHODS: Data on EAC incidence trends were abstracted from the SEER-9 registry (1975-2009) for the United States, from multiple cancer registries (1980-2004) in Spain, and from Eindhoven Cancer Registry in the Netherlands (1974-2010). In addition, we collected trend data on obesity, smoking, and alcohol consumption. The trend data were analyzed using log-linear regression. RESULTS: In 1980, the EAC incidence was similar among the three countries ((0.46-0.63) per 100,000). EAC incidence increased in all, with the largest increase observed in the Netherlands, followed by the United States and Spain (estimated annual percentage of change=9.7%, 7.4%, 4.3%, respectively). However, this pattern was not observed in lifestyle factors associated with EAC. With regards to obesity, the United States clearly has had the highest prevalence rates both in the past and in the present. For alcohol, the highest consumption rates are seen in Spain. Smoking showed a reverse trend compared with EAC among all three countries in the last 20 years. CONCLUSIONS: International trends in EAC incidence do not match corresponding trends in lifestyle-associated factors including obesity. Our findings suggest that factors other than obesity must be the important drivers for the increase in EAC incidence.
OBJECTIVES: The incidence of esophageal adenocarcinoma (EAC) in the western world has been rapidly increasing. The trends in obesity and other lifestyle-associated factors have been hypothesized to be important drivers of this increase. We tested this hypothesis by comparing changes in these factors with changes in EAC incidence over time between three western countries. METHODS: Data on EAC incidence trends were abstracted from the SEER-9 registry (1975-2009) for the United States, from multiple cancer registries (1980-2004) in Spain, and from Eindhoven Cancer Registry in the Netherlands (1974-2010). In addition, we collected trend data on obesity, smoking, and alcohol consumption. The trend data were analyzed using log-linear regression. RESULTS: In 1980, the EAC incidence was similar among the three countries ((0.46-0.63) per 100,000). EAC incidence increased in all, with the largest increase observed in the Netherlands, followed by the United States and Spain (estimated annual percentage of change=9.7%, 7.4%, 4.3%, respectively). However, this pattern was not observed in lifestyle factors associated with EAC. With regards to obesity, the United States clearly has had the highest prevalence rates both in the past and in the present. For alcohol, the highest consumption rates are seen in Spain. Smoking showed a reverse trend compared with EAC among all three countries in the last 20 years. CONCLUSIONS: International trends in EAC incidence do not match corresponding trends in lifestyle-associated factors including obesity. Our findings suggest that factors other than obesity must be the important drivers for the increase in EAC incidence.
Authors: Jessie Steevens; Anita A M Botterweck; Miranda J M Dirx; Piet A van den Brandt; Leo J Schouten Journal: Eur J Gastroenterol Hepatol Date: 2010-06 Impact factor: 2.566
Authors: Esteve Fernández; Anna Schiaffino; Montse García; Esteve Saltó; Joan Ramon Villalbí; Josep Maria Borràs Journal: Med Clin (Barc) Date: 2003-01-18 Impact factor: 1.725
Authors: James P Moriarty; Nilay D Shah; Joel H Rubenstein; Christopher H Blevins; Michele Johnson; David A Katzka; Kenneth K Wang; Louis Michel Wongkeesong; David A Ahlquist; Prasad G Iyer Journal: Gastrointest Endosc Date: 2017-04-25 Impact factor: 9.427
Authors: Melina Arnold; Amy Colquhoun; Michael B Cook; Jacques Ferlay; David Forman; Isabelle Soerjomataram Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-10-22 Impact factor: 4.254
Authors: Ming Yu; Rachele M O'Leary; Andrew M Kaz; Shelli M Morris; Kelly T Carter; Amitabh Chak; Apoorva Chandar; Joseph E Willis; Helen R Moinova; Sanford D Markowitz; Dean E Brenner; Sharmila Anandabapasathy; Maria Westerhoff; Chao-Jen Wong; Nicholas J Shaheen; Yanwen Chen; Jill S Barnholtz-Sloan; William M Grady Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-11-06 Impact factor: 4.254